JARDIANCE 10MG 30TAB

JARDIANCE 10 mg Tablets – 30 Tablets Active Ingredient: Empagliflozin 10 mg Therapeutic Class: Oral Antidiabetic – SGLT2 InhibitorDescription: JARDIANCE contains empagliflozin, an SGLT2 inhibitor that lowers blood sugar by increasing glucose excretion through urine. It is used to manage type 2 diabetes and has shown benefits in reducing cardiovascular risks.Indications: Treatment of type 2 diabetes in adults as an adjunct to diet and exercise Reduces risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease Dosage: One tablet (10 mg) once daily in the morning, with or without food Dose adjustment based on kidney function Contraindications: Type 1 diabetes Diabetic ketoacidosis Severe renal impairment Hypersensitivity to empagliflozin Warnings: Risk of urinary tract and genital infections Monitor kidney function and hydration Not recommended during pregnancy or breastfeeding Side Effects: Increased urination Genital infections Thirst and dizziness Storage: Store below 30°C in a dry place away from sunlight.